Blood-based biomarkers of Alzheimer's disease: Standardization and comprehensiveness
{{output}}
Population aging is sweeping across the globe, resulting in a striking prevalence of Alzheimer's disease (AD) and dementia and a heavy economic burden. Given the time window of 10-20 years from pathological initiation to clinically detected cognitive impairme... ...